103 related articles for article (PubMed ID: 880435)
1. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
Huot S; Lippert B; Palfreyman MG; Schechter PJ
Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
[No Abstract] [Full Text] [Related]
2. Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems.
McGeer PL; McGeer EG; Hattori T
Adv Biochem Psychopharmacol; 1977; 16():397-402. PubMed ID: 329651
[No Abstract] [Full Text] [Related]
3. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
[No Abstract] [Full Text] [Related]
4. The effect of gamma-acetylenic GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase, on dopamine pathways of the extrapyramidal and limbic systems.
Palfreyman MG; Huot S; Lippert B; Schechter PJ
Eur J Pharmacol; 1978 Aug; 50(4):325-36. PubMed ID: 699960
[TBL] [Abstract][Full Text] [Related]
5. Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions.
Di Chiara G; Morelli M; Acquas E; Carboni E
Arzneimittelforschung; 1992 Feb; 42(2A):231-7. PubMed ID: 1586394
[TBL] [Abstract][Full Text] [Related]
6. Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.
Fuxe K; Hökfelt T; Ljungdahl A; Agnati L; Johansson O; Perez de la Mora M
Med Biol; 1975 Jun; 53(3):177-83. PubMed ID: 1160412
[TBL] [Abstract][Full Text] [Related]
7. Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.
Bartholini G; Stadler H; Gadea-Ciria M; Lloyd KG
Adv Biochem Psychopharmacol; 1977; 16():391-5. PubMed ID: 18888
[No Abstract] [Full Text] [Related]
8. [Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry].
Bartholini G
Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):265-9. PubMed ID: 45343
[TBL] [Abstract][Full Text] [Related]
9. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
Bartholini G
Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
[No Abstract] [Full Text] [Related]
10. Potentiation of gamma-aminobutyric acid (GABA) action by inhibiting neuroglial uptake [proceedings].
Galvan M; Brown DA
Br J Pharmacol; 1977 Mar; 59(3):485P-486P. PubMed ID: 843723
[No Abstract] [Full Text] [Related]
11. Inhibition of substance P release from the isolated rat substantia nigra by GABA [proceedings].
Jessell TM; Iversen LL
Br J Pharmacol; 1977 Mar; 59(3):486P. PubMed ID: 843724
[No Abstract] [Full Text] [Related]
12. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
[TBL] [Abstract][Full Text] [Related]
13. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
Bartholini G; Scatton B; Zivkovic B
Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
[TBL] [Abstract][Full Text] [Related]
14. Gaba blockade, dopamine and schizophrenia: experimental activation of the mesolimbic system.
Stevens JR
Int J Neurol; 1975; 10(1-4):115-27. PubMed ID: 1237474
[No Abstract] [Full Text] [Related]
15. In vivo effects of GABA uptake inhibitors on the response of cat spinal neurones to GABA analogues [proceedings].
Curtis DR; Johnston GA; Lodge D
Br J Pharmacol; 1977 Sep; 61(1):148P. PubMed ID: 912196
[No Abstract] [Full Text] [Related]
16. Quantitative evaluation of evoked potentials after administration of gama-aminobutyric acid (GABA) and its structural analogues to adult rats.
Rokyta R; Safanda J; Sobotka P
Act Nerv Super (Praha); 1976 Jun; 18(1-2):110-1. PubMed ID: 941630
[No Abstract] [Full Text] [Related]
17. GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease.
Bartholini G; Scatton B; Zivkovic B; Lloyd KG
Adv Neurol; 1987; 45():79-83. PubMed ID: 3030072
[TBL] [Abstract][Full Text] [Related]
18. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents.
Costall B; Naylor RJ
Neuropharmacology; 1974 May; 13(5):353-64. PubMed ID: 4607196
[No Abstract] [Full Text] [Related]
19. Development of the glutamate, GABA, and dopamine systems in relation to NRH-induced neurotoxicity.
Benes FM
Biol Psychiatry; 1995 Dec; 38(12):783-7. PubMed ID: 8750035
[No Abstract] [Full Text] [Related]
20. [Effect of gamma-aminobutyric acid and phenibut on the central links of the vascular reflexes with chemo- and mechanoreceptors of the aorto-carotid zone].
Kovalev GV; Morozov IS
Biull Eksp Biol Med; 1975 Apr; 79(4):71-5. PubMed ID: 1191772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
